AU2003222513A1 - Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure - Google Patents
Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failureInfo
- Publication number
- AU2003222513A1 AU2003222513A1 AU2003222513A AU2003222513A AU2003222513A1 AU 2003222513 A1 AU2003222513 A1 AU 2003222513A1 AU 2003222513 A AU2003222513 A AU 2003222513A AU 2003222513 A AU2003222513 A AU 2003222513A AU 2003222513 A1 AU2003222513 A1 AU 2003222513A1
- Authority
- AU
- Australia
- Prior art keywords
- cardiomyopathy
- preventing
- heart failure
- vascular disease
- treating vascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000031229 Cardiomyopathies Diseases 0.000 title 1
- 206010019280 Heart failures Diseases 0.000 title 1
- 208000019553 vascular disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ517722 | 2002-03-08 | ||
NZ51772202 | 2002-03-08 | ||
PCT/NZ2003/000043 WO2003075910A1 (en) | 2002-03-08 | 2003-03-10 | Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003222513A1 true AU2003222513A1 (en) | 2003-09-22 |
Family
ID=27800845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003222513A Abandoned AU2003222513A1 (en) | 2002-03-08 | 2003-03-10 | Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003222513A1 (en) |
WO (1) | WO2003075910A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198334B2 (en) * | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
EP1115389B1 (en) | 1998-09-25 | 2014-03-12 | PhilERA New Zealand Limited | Fructosamine oxidase: antagonists and inhibitors |
CN102526044A (en) * | 2001-12-06 | 2012-07-04 | 法布罗根股份有限公司 | Methods of increasing endogenous erythropoietin EPO |
WO2003077901A1 (en) * | 2002-03-08 | 2003-09-25 | Protemix Corporation Limited | Preventing and/or treating cardiovascular disease and/or associated heart failure |
MXPA05002883A (en) * | 2002-08-20 | 2005-10-05 | Protemix Corp Ltd | Dosage forms and related therapies. |
AU2003263948A1 (en) * | 2002-08-22 | 2004-03-11 | University Of Florida | Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
CN1812776A (en) * | 2003-05-21 | 2006-08-02 | 得克萨斯州大学系统董事会 | Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
EP1778618B1 (en) | 2004-07-19 | 2013-12-25 | PhilERA New Zealand Limited | Synthesis of triethylenetetramines |
WO2006104401A1 (en) * | 2005-03-26 | 2006-10-05 | Protemix Corporation Limited | Copper antagonist compositions |
WO2006132583A1 (en) * | 2005-06-07 | 2006-12-14 | Innate Pharmaceuticals Ab | Method and means for preventing and inhibiting respiratory disease, atherosclerosis and osteoporosis caused by chlamydia pneumoniae infection |
MX2009010407A (en) | 2007-03-28 | 2009-12-01 | Apotex Technologies Inc | Fluorinated derivatives of deferiprone. |
CN102014904B (en) | 2008-04-25 | 2013-02-06 | 阿普泰克斯科技公司 | Liquid formulation for deferiprone with palatable taste |
WO2010020959A1 (en) * | 2008-08-21 | 2010-02-25 | University Of Cape Town | Resveratrol-containing composition for treating heart failure |
WO2011000104A1 (en) | 2009-07-03 | 2011-01-06 | Apotex Technologies Inc. | Fluorinated derivatives of 3-hydroxypyridin-4-ones |
US10478455B2 (en) | 2010-03-30 | 2019-11-19 | Ucl Business Ltd | Therapeutic use of tetrathiomolybdate |
GB201005394D0 (en) * | 2010-03-30 | 2010-05-12 | Magnus Intellectual Property Ltd | Therapy |
US10369108B2 (en) | 2013-03-15 | 2019-08-06 | Mylan Laboratories, Inc. | Hot melt granulation formulations of poorly water-soluble active agents |
WO2017168414A1 (en) * | 2016-03-28 | 2017-10-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Iron chelators and combination thereof for the treatment of wolfram syndrome 2 |
EA202092241A1 (en) | 2018-05-04 | 2021-04-01 | Орфалан | CRYSTALLINE FORM OF TRIETHYLENTETHRAMINE TETRAHYDROCHLORIDE AND ITS PHARMACEUTICAL APPLICATION |
CN110746511B (en) * | 2019-10-09 | 2021-05-28 | 安徽金太阳食品有限公司 | Method for preparing modified starch for papermaking sizing agent from broken rice leftover in rice production |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6147070A (en) * | 1998-06-05 | 2000-11-14 | Facchini; Francesco | Methods and compositions for controlling iron stores to treat and cure disease states |
-
2003
- 2003-03-10 WO PCT/NZ2003/000043 patent/WO2003075910A1/en not_active Application Discontinuation
- 2003-03-10 AU AU2003222513A patent/AU2003222513A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003075910A1 (en) | 2003-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003222513A1 (en) | Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure | |
AU2002331563A1 (en) | Physiological heart pump control | |
AU2003214725A1 (en) | Preventing and/or treating cardiovascular disease and/or associated heart failure | |
ZA200108218B (en) | Vascular surgery. | |
AU2003259537A1 (en) | Blood glucose level control | |
AU2002336030A1 (en) | Methods for preventing, treating or delaying cardiac toxicity using neuregulin | |
AU2002320610A1 (en) | Tissue engineered heart valve | |
AU2003233437A1 (en) | System for the diagnosis and monitoring of coronary artery disease, acute coronary syndromes, cardiomyopathy and other cardiac conditions | |
HK1084037A1 (en) | Medicament for treating severe heart failure | |
MXPA01012635A (en) | Heart assist devices, systems and methods. | |
AU2001289640A1 (en) | Intracardiac blood pump | |
AU2003257613A1 (en) | Catheter for treating irregular heart pulse | |
AU2003206949A1 (en) | Venous prosthesis | |
AU2001284413A1 (en) | Medicinal compositions for preventing or treating heart failure | |
AU2002367023A1 (en) | Compositions and methods for treating heart failure | |
AU2003291536A1 (en) | Method for the diagnosis and treatment of vascular disease | |
AU2002365057A1 (en) | Compositions and methods for treating heart failure | |
EP1591113A4 (en) | Blood pressure-lowering agent, vascular flexibility-improving agent and foods having these functions imparted thereto | |
AU6648200A (en) | Method and composition for preventing or treating adverse physiological effects associated with cardiac disease | |
AU2003230552A1 (en) | Methods for treating or inhibiting sick building syndrome, post-lyme disease syndrome, and/or chronic fatigue syndrome | |
WO2005115517A3 (en) | Methods of treating diabetes | |
IS8356A (en) | Medications, methods and dose control for the treatment and prevention of acute coronary heart disease | |
PT1487431E (en) | Preventing and/or treating cardiovascular disease and/or associated heart failure | |
AU2003239445A1 (en) | Medical clothing | |
AUPS020602A0 (en) | Treatment for heart failure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |